/ResMed%20headquarters%20By%20JHVEPhoto.jpeg)
With a market cap of $33.5 billion, ResMed Inc. (RMD) is a global health technology company that develops innovative solutions to help people live healthier, happier lives through better sleep and breathing. Operating across 140 countries, the company combines AI-powered digital health solutions, cloud-connected devices, and intelligent software to make home healthcare more personalized, accessible, and effective.
Shares of the San Diego, California-based company have underperformed the broader market over the past 52 weeks. RMD stock has decreased 18.7% over this time frame, while the broader S&P 500 Index ($SPX) has gained 19.3%. Moreover, the stock has fallen 3.6% on a YTD basis, compared to SPX's 12.2% return.
